COLGATE-PALMOLIVE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.01 USD | +1.93% |
|
+4.45% | +14.18% |
| Apr. 26 | HSBC Raises Colgate-Palmolive's Price Target to $98 From $89 | MT |
| Apr. 26 | Sector Update: Consumer Stocks Mixed Pre-Bell Friday | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 58,999 | 73,297 | 71,929 | 65,807 | 65,631 | 74,668 | - | - |
| Enterprise Value (EV) 1 | 65,963 | 80,010 | 78,342 | 73,798 | 73,214 | 82,143 | 81,846 | 81,530 |
| P/E ratio | 25 x | 27.2 x | 33.5 x | 37 x | 28.8 x | 26.1 x | 23.9 x | 21.8 x |
| Yield | 2.48% | 2.05% | 2.1% | 2.36% | 2.4% | 2.24% | 2.33% | 2.4% |
| Capitalization / Revenue | 3.76 x | 4.45 x | 4.13 x | 3.66 x | 3.37 x | 3.7 x | 3.55 x | 3.42 x |
| EV / Revenue | 4.2 x | 4.86 x | 4.5 x | 4.11 x | 3.76 x | 4.07 x | 3.89 x | 3.73 x |
| EV / EBITDA | 15.7 x | 18.1 x | 17.7 x | 17.5 x | 15.9 x | 16.5 x | 15.5 x | 14.5 x |
| EV / FCF | 23.6 x | 24.2 x | 28.4 x | 39.7 x | 24.1 x | 27 x | 24.6 x | 22.9 x |
| FCF Yield | 4.24% | 4.14% | 3.52% | 2.52% | 4.15% | 3.71% | 4.07% | 4.37% |
| Price to Book | 505 x | 98.3 x | 118 x | 164 x | 108 x | 68.3 x | 45.3 x | 28 x |
| Nbr of stocks (in thousands) | 857,044 | 857,169 | 842,849 | 835,214 | 823,372 | 820,441 | - | - |
| Reference price 2 | 68.84 | 85.51 | 85.34 | 78.79 | 79.71 | 91.01 | 91.01 | 91.01 |
| Announcement Date | 1/31/20 | 1/29/21 | 1/28/22 | 1/27/23 | 1/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 15,693 | 16,471 | 17,421 | 17,967 | 19,457 | 20,172 | 21,019 | 21,851 |
| EBITDA 1 | 4,192 | 4,414 | 4,433 | 4,226 | 4,603 | 4,972 | 5,272 | 5,628 |
| EBIT 1 | 3,673 | 3,875 | 3,877 | 3,681 | 4,036 | 4,351 | 4,625 | 4,957 |
| Operating Margin | 23.41% | 23.53% | 22.25% | 20.49% | 20.74% | 21.57% | 22% | 22.69% |
| Earnings before Tax (EBT) 1 | 3,301 | 3,647 | 3,087 | 2,660 | 3,392 | 4,046 | 4,322 | 4,668 |
| Net income 1 | 2,367 | 2,695 | 2,166 | 1,785 | 2,300 | 2,897 | 3,101 | 3,355 |
| Net margin | 15.08% | 16.36% | 12.43% | 9.93% | 11.82% | 14.36% | 14.75% | 15.35% |
| EPS 2 | 2.750 | 3.140 | 2.550 | 2.130 | 2.770 | 3.486 | 3.812 | 4.166 |
| Free Cash Flow 1 | 2,798 | 3,309 | 2,758 | 1,860 | 3,040 | 3,044 | 3,331 | 3,560 |
| FCF margin | 17.83% | 20.09% | 15.83% | 10.35% | 15.62% | 15.09% | 15.85% | 16.29% |
| FCF Conversion (EBITDA) | 66.75% | 74.97% | 62.22% | 44.01% | 66.04% | 61.23% | 63.19% | 63.25% |
| FCF Conversion (Net income) | 118.21% | 122.78% | 127.33% | 104.2% | 132.17% | 105.1% | 107.41% | 106.11% |
| Dividend per Share 2 | 1.710 | 1.750 | 1.790 | 1.860 | 1.910 | 2.034 | 2.118 | 2.189 |
| Announcement Date | 1/31/20 | 1/29/21 | 1/28/22 | 1/27/23 | 1/26/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,403 | 4,399 | 4,484 | 4,455 | 4,629 | 4,770 | 4,822 | 4,915 | 4,950 | 5,065 | 4,999 | 5,066 | 5,157 | 5,150 | 5,172 |
| EBITDA 1 | 1,078 | 1,061 | 1,035 | 1,054 | 1,076 | 1,067 | 1,137 | 1,175 | 1,224 | 1,233 | 1,198 | 1,218 | 1,284 | 1,249 | 1,300 |
| EBIT 1 | 936 | 923 | 897 | 920 | 941 | 939 | 992 | 1,031 | 1,074 | 1,083 | 1,068 | 1,086 | 1,150 | 1,082 | 1,127 |
| Operating Margin | 21.26% | 20.98% | 20% | 20.65% | 20.33% | 19.69% | 20.57% | 20.98% | 21.7% | 21.38% | 21.36% | 21.43% | 22.29% | 21.01% | 21.79% |
| Earnings before Tax (EBT) 1 | 324 | 795 | 841 | 892 | 132 | 561 | 887 | 956 | 988 | 967 | 972.7 | 997.7 | 1,067 | 1,006 | 1,059 |
| Net income 1 | 148 | 559 | 603 | 618 | 5 | 372 | 502 | 708 | 718 | 683 | 703.4 | 706.1 | 763.2 | 715.6 | 765.5 |
| Net margin | 3.36% | 12.71% | 13.45% | 13.87% | 0.11% | 7.8% | 10.41% | 14.4% | 14.51% | 13.48% | 14.07% | 13.94% | 14.8% | 13.9% | 14.8% |
| EPS 2 | 0.1800 | 0.6600 | 0.7200 | 0.7400 | 0.0100 | 0.4500 | 0.6000 | 0.8600 | 0.8700 | 0.8300 | 0.8561 | 0.8740 | 0.9413 | 0.9000 | 0.9300 |
| Dividend per Share 2 | 0.4500 | 0.4500 | 0.4700 | 0.4700 | 0.4700 | 0.4800 | 0.4800 | 0.4800 | 0.4800 | - | 0.5190 | 0.4984 | 0.5417 | 0.4971 | 0.5480 |
| Announcement Date | 1/28/22 | 4/29/22 | 7/29/22 | 10/28/22 | 1/27/23 | 4/28/23 | 7/28/23 | 10/27/23 | 1/26/24 | 4/26/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 6,964 | 6,713 | 6,413 | 7,991 | 7,583 | 7,475 | 7,178 | 6,862 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.661 x | 1.521 x | 1.447 x | 1.891 x | 1.647 x | 1.503 x | 1.362 x | 1.219 x |
| Free Cash Flow 1 | 2,798 | 3,309 | 2,758 | 1,860 | 3,040 | 3,045 | 3,331 | 3,560 |
| ROE (net income / shareholders' equity) | 646% | 627% | 402% | 494% | 957% | 303% | 236% | 170% |
| ROA (Net income/ Total Assets) | 17.9% | 17% | 17.6% | 11.6% | 14.3% | 17.4% | 18.1% | 18.7% |
| Assets 1 | 13,191 | 15,853 | 12,332 | 15,386 | 16,061 | 16,679 | 17,131 | 17,948 |
| Book Value Per Share 2 | 0.1400 | 0.8700 | 0.7200 | 0.4800 | 0.7400 | 1.330 | 2.010 | 3.250 |
| Cash Flow per Share 2 | 3.640 | 4.330 | 3.920 | 3.050 | 4.520 | 4.400 | 4.850 | 5.310 |
| Capex 1 | 335 | 410 | 567 | 696 | 705 | 674 | 749 | 786 |
| Capex / Sales | 2.13% | 2.49% | 3.25% | 3.87% | 3.62% | 3.34% | 3.56% | 3.6% |
| Announcement Date | 1/31/20 | 1/29/21 | 1/28/22 | 1/27/23 | 1/26/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
91.01
USD
Average target price
92.54
USD
Spread / Average Target
+1.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.18% | 74.67B | |
| +10.07% | 381B | |
| -16.59% | 62.59B | |
| +0.82% | 52.86B | |
| -12.40% | 36.11B | |
| +3.54% | 33.57B | |
| +7.92% | 17.29B | |
| +6.30% | 14.75B | |
| -8.65% | 10.82B | |
| +12.89% | 9.31B |
- Stock Market
- Equities
- CL Stock
- Financials Colgate-Palmolive Company
